NASDAQ
$22.97
(1.86%)
Subscribe to get
AI Score
The main point of investing for the long term is to make money. Furthermore, you'd generally like to...
Investors looking for stocks in the Medical - Drugs sector might want to consider either Sandoz...
Free Report) . Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important ...
Leerink Partnrs upgraded shares of Zoetis (NYSE:ZTS – Free Report) to a strong-buy rating in a report published on Monday,Zacks.com reports. Leerink Partnrs also issued estimates for Zoetis’ ...
Zoetis Inc. (NYSE:ZTS – Free Report) – Stock analysts at Zacks Research boosted their Q1 2026 earnings per share estimates for Zoetis in a note issued to investors on Tuesday, December 3rd.
Performance of an Industry Player Catalent belongs to the Zacks Medical - Drugs industry. Another...
DOMESTIC ASSAULT: On Nov. 28 officers were dispatched to a residence for a possible domestic assault altercation. When officers arrived on the scene, a male exited the residence. One officer